SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022
- PMID: 35113851
- PMCID: PMC8812833
- DOI: 10.15585/mmwr.mm7105e1
SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022
Abstract
COVID-19 vaccines are effective at preventing infection with SARS-CoV-2, the virus that causes COVID-19, as well as severe COVID-19-associated outcomes in real-world conditions (1,2). The risks for SARS-CoV-2 infection and COVID-19-associated hospitalization are lower among fully vaccinated than among unvaccinated persons; this reduction is even more pronounced among those who have received additional or booster doses (boosters) (3,4). Although the B.1.1.529 (Omicron) variant spreads more rapidly than did earlier SARS-CoV-2 variants, recent studies suggest that disease severity is lower for Omicron compared with that associated with the B.1.617.2 (Delta) variant; but the high volume of infections is straining the health care system more than did previous waves (5).*,† The Los Angeles County (LAC) Department of Public Health (LACDPH) used COVID-19 surveillance and California Immunization Registry 2 (CAIR2) data to describe age-adjusted 14-day cumulative incidence and hospitalization rates during November 7, 2021-January 8, 2022, by COVID-19 vaccination status and variant predominance. For the 14-day period ending December 11, 2021, the last week of Delta predominance, the incidence and hospitalization rates among unvaccinated persons were 12.3 and 83.0 times, respectively, those of fully vaccinated persons with a booster and 3.8 and 12.9 times, respectively, those of fully vaccinated persons without a booster. These rate ratios were lower during Omicron predominance (week ending January 8, 2022), with unvaccinated persons having infection and hospitalization rates 3.6 and 23.0 times, respectively, those of fully vaccinated persons with a booster and 2.0 and 5.3 times, respectively, those of fully vaccinated persons without a booster. In addition, during the entire analytic period, admission to intensive care units (ICUs), intubation for mechanical ventilation, and death were more likely to occur among unvaccinated persons than among fully vaccinated persons without or with a booster (p<0.001). Incidence and hospitalization rates were consistently highest for unvaccinated persons and lowest for fully vaccinated persons with a booster. Being up to date with COVID-19 vaccination is critical to protecting against SARS-CoV-2 infection and associated hospitalization.
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Figures
Similar articles
-
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34437525 Free PMC article.
-
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35143466 Free PMC article.
-
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35085222 Free PMC article.
-
Does the COVID-19 Vaccination Reduce the Risk to Transmit SARS-CoV-2 to Others?Adv Exp Med Biol. 2024;1457:247-264. doi: 10.1007/978-3-031-61939-7_14. Adv Exp Med Biol. 2024. PMID: 39283431 Review.
-
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis.Infect Dis Poverty. 2021 Nov 14;10(1):132. doi: 10.1186/s40249-021-00915-3. Infect Dis Poverty. 2021. PMID: 34776011 Free PMC article. Review.
Cited by
-
The effectiveness of COVID-19 vaccination in preventing hospitalisation and mortality: A nationwide cross-sectional study in Iran.J Glob Health. 2024 Sep 27;14:05026. doi: 10.7189/jogh.14.05026. J Glob Health. 2024. PMID: 39325919 Free PMC article.
-
Changes in Self-Reported Mask Use After the Lifting of State-Issued Mask Mandates in 20 US States, February-June 2021.J Public Health Manag Pract. 2024 Nov-Dec 01;30(6):E335-E343. doi: 10.1097/PHH.0000000000002036. Epub 2024 Sep 3. J Public Health Manag Pract. 2024. PMID: 39231391 Free PMC article.
-
Association of Prior COVID-19 Infection with Risk of Breakthrough Infection Following Vaccination: A Cohort Study in Isfahan, Iran.Int J Prev Med. 2024 Jul 17;15:18. doi: 10.4103/ijpvm.ijpvm_173_23. eCollection 2024. Int J Prev Med. 2024. PMID: 39170924 Free PMC article.
-
Construction and validation of a risk model of proteinuria in patients with omicron COVID-19: retrospective cohort study.Ren Fail. 2024 Dec;46(2):2365979. doi: 10.1080/0886022X.2024.2365979. Epub 2024 Aug 6. Ren Fail. 2024. PMID: 39108141 Free PMC article.
-
Impact of vaccine coverage and disruption to health services on COVID-19 in Ukraine.Sci Rep. 2024 Jun 26;14(1):14729. doi: 10.1038/s41598-024-57447-7. Sci Rep. 2024. PMID: 38926448 Free PMC article.
References
-
- Food and Drug Administration. Coronavirus (COVID-19) update: FDA expands eligibility for COVID-19 vaccine boosters. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2021. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19...
-
- Iuliano AD, Brunkard JM, Boehmer TK, et al. Trends in disease severity and health care utilization during the early Omicron variant period compared with previous SARS-CoV-2 high transmission periods—United States, December 2020–January 2022. MMWR Morb Mortal Wkly Rep 2022;71:146–52. 10.15585/mmwr.mm7104e4 - DOI - PMC - PubMed
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
